Epstein‐Barr virus in systemic autoimmune diseases
AH Draborg, K Duus, G Houen - Journal of Immunology …, 2013 - Wiley Online Library
Systemic autoimmune diseases (SADs) are a group of connective tissue diseases with
diverse, yet overlapping, symptoms and autoantibody development. The etiology behind …
diverse, yet overlapping, symptoms and autoantibody development. The etiology behind …
Genetic susceptibility to SLE: recent progress from GWAS
Y Cui, Y Sheng, X Zhang - Journal of autoimmunity, 2013 - Elsevier
Systemic lupus erythematosus (SLE) is a prototype autoimmune disease with a strong
genetic component, characterized by hyperactive T and B cells, autoantibody production …
genetic component, characterized by hyperactive T and B cells, autoantibody production …
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
Y Jin, SA Birlea, PR Fain, TM Ferrara, S Ben… - Nature …, 2012 - nature.com
We previously reported a genome-wide association study (GWAS) identifying 14
susceptibility loci for generalized vitiligo. We report here a second GWAS (450 individuals …
susceptibility loci for generalized vitiligo. We report here a second GWAS (450 individuals …
USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase
Lys63-linked polyubiquitination of RIG-I is essential in antiviral immune defense, yet the
molecular mechanism that negatively regulates this critical step is poorly understood. Here …
molecular mechanism that negatively regulates this critical step is poorly understood. Here …
Epstein‐Barr virus and systemic lupus erythematosus
AH Draborg, K Duus, G Houen - Journal of Immunology …, 2012 - Wiley Online Library
The etiology of SLE is not fully established. SLE is a disease with periods of waning disease
activity and intermittent flares. This fits well in theory to a latent virus infection, which …
activity and intermittent flares. This fits well in theory to a latent virus infection, which …
[HTML][HTML] The genetics of lupus: a functional perspective
SG Guerra, TJ Vyse… - Arthritis research & …, 2012 - Springer
Systemic lupus erythematosus (SLE) is an autoimmune disease with a strong genetic
component and is characterized by chronic inflammation and the production of anti-nuclear …
component and is characterized by chronic inflammation and the production of anti-nuclear …
[HTML][HTML] Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci
C Shen, J Gao, Y Sheng, J Dou, F Zhou, X Zheng… - Frontiers in …, 2016 - frontiersin.org
Vitiligo is an autoimmune disease with a strong genetic component, characterized by areas
of depigmented skin resulting from loss of epidermal melanocytes. Genetic factors are …
of depigmented skin resulting from loss of epidermal melanocytes. Genetic factors are …
Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases
I Grosjean, B Roméo, MA Domdom, A Belaid… - Autophagy, 2022 - Taylor & Francis
At a time when complex diseases affect globally 280 million people and claim 14 million
lives every year, there is an urgent need to rapidly increase our knowledge into their …
lives every year, there is an urgent need to rapidly increase our knowledge into their …
[PDF][PDF] Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF blockade with tabalumab
RW Hoffman, JT Merrill… - Arthritis & …, 2017 - Wiley Online Library
Objective To characterize baseline gene expression and pharmacodynamically induced
changes in whole blood gene expression in 1,760 systemic lupus erythematosus (SLE) …
changes in whole blood gene expression in 1,760 systemic lupus erythematosus (SLE) …
Current aspects of vitiligo genetics
R Czajkowski, K Męcińska-Jundziłł - Advances in Dermatology and …, 2014 - termedia.pl
Vitiligo is a common acquired depigmentation disorder of the skin manifested by the
presence of white macules. The disease occurs at a frequency of approximately 1–4% of the …
presence of white macules. The disease occurs at a frequency of approximately 1–4% of the …